The role of renal natriuretic and depressor systems in insulin-resistant hypertensive rats

Hypertension Research

Volumn 27, Issue 7, 2004, Pages 501-508

  Hasegawa, Koichi ^a   Yoshida, Hideaki ^a   Ura, Nobuyuki ^a   Murakami, Hideyuki ^a   Hagiwara, Makoto ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine; Hypertension; Insulin resistance; Kallikrein; Nitric oxides

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRUCTOSE; INSULIN; KALLIKREIN; MESSENGER RNA; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORRELATION FUNCTION; DIETARY INTAKE; ENZYME ACTIVITY; HYPERTENSION; INSULIN RESISTANCE; KIDNEY DYSFUNCTION; LOADING TEST; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT STRAIN; RENAL SYSTEM PARAMETERS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; URINE LEVEL;

ANIMALS; DOPAMINE; HYPERTENSION; INSULIN RESISTANCE; KALLIKREINS; KIDNEY; MALE; NITRATES; NITRITES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 4344629519     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.501     Document Type: Article

References (44)

1. DeFronzo RA, Ferrannini E: Insulin resistance - a multifactorial syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
2. DeFronzo RA: Insulin resistance, hyperinsulinemia and coronary artery disease. J Cardiovasc Pharmacol 1992; 20: S1-S16.
3. Agata J, Miyazaki Y, Takada M, et al: Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension. Hypertens Res 1998; 21: 57-62.
4. Jarrett RJ, Keen H, McCartney M, et al: Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol 1978; 7: 15-24.
5. Modan M, Halkin H, Almong S, et al: Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
6. Defronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in men. J Clin Invest 1975; 55: 845-855.
7. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal in man. Diabetes 1981; 30: 219-225.
8. Berne C, Fagius J, Pollare T, Hjemdahl P: The sympathetic response to euglycaemic hyperinsulinemia. Diabetologia 1992; 35: 873-879.
9. Hwang I, Ho H, Hoffman B, Reaven GM: Fructose induced insulin resistance and hypertension in rats. Hypertension 1987; 10: 512-516.
10. Higashiura K, Ura N, Takada T, et al: Alteration of muscle fiber composition linking to insulin resistance and hypertension in fructose-fed rats. Am J Hypertens 1909; 12: 596-602.
11. Navarro-Cid J, Maeso R, Perez-Vizcaino F, et al: Effects of antihypertensive drugs on blood pressure and metabolic alteration in the fructose-induced hypertensive rats. Am J Hypertens 1996; 9: 669-674.
12. Togashi N, Ura N, Higashiura K, Murakami H, Shimamoto K: The contribution of skeletal muscle tumor necrosis factor-α to insulin resistance and hypertension in fructose-fed rats. J Hypertens 2000; 18: 1605 -1610.
13. Lee MR: Dopamine and the kidney: ten years on. Clin Sci 1993; 84: 357-375.
14. Hubbard PC, Henderson IW: Renal dopamine and the tubular handling of sodium. J Mol Endocrinol 1995; 14: 139-155.
15. Margolius HS, Geller RG, Pisano JJ, Sjoerdsma A: Altered urinary kallikrein excretion in human hypertension. Lancet 1971; 2: 1063-1065.
16. Iimura O, Shimamoto K, Ura N, et al: The pathophysiological role of renal dopamine, kallikrein-kinin and prostaglandin systems in essential hypertension. Agents Actions Suppl 1987; 22: 247-256.
17. Margolius HS, Geller R, De Jong W, Pisano JJ, Sjoerdsma A: Altered urinary kallikrein excretion in rats with hypertension. Circ Res 1972; 30: 358-362.
18. Kuchel O, Shigetomi S: Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients. Hypertension 1992; 19: 634-638.
19. Cowley AW Jr, Mattson DL, Lu S, Roman RJ: The renal medulla and hypertension. Hypertension 1995; 25: 663-673.
20. Ikenaga H, Suzuki H, Ishii N, Itoh H, Saruta T: Role of NO on pressure-natriuresis in Wistar-Kyoto and spontaneously hypertensive rats. Kidney Int 1993; 43: 205-211.
21. Barton M, Vos I, Shaw S, et al: Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis. J Am Soc Nephrol 2000; 11: 835-846.
22. Hayashi M, Takizawa H, Tsuchihashi K, Ura N, Shimamoto K: Changes of urinary dopamine excretion early after balloon mitral commissurotomy in mitral stenosis. Clin Exp Pharmacol Physiol 1999; 26: 634-638.
23. Shimamoto K, Tanaka S, Nakao T, et al: Measurement of urinary kallikrein activity by kinin radioimmunoassay. Jpn Circ J 1979; 43: 147-152.
24. Leenen FHH, De Jong W: Plasma renin and sodium balance during development of moderate and severe renal hypertension in rats. Circ Res 1975; 36 (6 Suppl 1): 179-186.
25. Soares-da-Silva P, Fernandes MH, Pintodo-O PC: Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br J Pharmacol 1994; 112: 611-615.
26. Brismar H, Asghar M, Carey RM, Greengard P, Aperia A: Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci USA 1998; 95: 5573-5578.
27. Gill JR Jr, Gullner G, Lake CR, Lakatua DJ, Lan G: Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 1988; 11: 312-319.
28. Jose PA, Eisner GM, Felder RA: The renal dopamine receptors in health and hypertension. Pharmacol Ther 1998; 80: 149-182.
29. Ragsdale NV, Lynch M, Chevalier RL, Felder RA, Peach MJ, Carey RM: Selective peripheral dopamine-1 receptor stimulation: differential responses to sodium loading and depletion. Hypertension 1990; 15: 914-921.
30. Pelayo JC, Fildes RD, Eisner GM, Jose PA: Effective dopamine blockade on renal sodium excretion. Am J Physiol 1983; 245: F247-F253.
31. Hansell P, Fasching A: The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypovolemia. Kindey Int 1991; 39: 253-258.
32. - imbalance in insulin-resistant rat aorta. Diabetes 1999; 48: 2437-2445.
33. Kuboki K, Jiang ZY, Takahara N, et al: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000; 101: 676-681.
34. Galletti F, Strazzullo P, Ferrara I, et al: NaCl sensitivity of essential hypertensive patients is related to insulin resistance. J Hypertens 1997; 15: 1485-1491.
35. Facchini FS, DoNascimento C, Reaven GM, Yip JW, Ni XP, Humphreys MH: Blood pressure, sodium intake, insulin resistance, and urinary nitrate excretion. Hypertension 1999; 33: 1008-1012.
36. Fujiwara K, Hayashi K, Matsuda H, et al: Altered pressure-natriuresis in obese Zucker rats. Hypertension 1999; 33: 1470-1475.
37. Sechi LA: Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity. J Hypertens 1999; 17: 1229-1237.
38. Lee DH, Lee JU, Kang DG, Pack YW, Chung DJ, Chung MY: Increased vascular endothelin-1 gene expression with unaltered nitric oxide synthase levels in fructose-induced hypertensive rats. Metabolism 2001; 50: 74-78.
39. Miatello R, Risler N, Castro C, González S, Rüttler M, Cruzado M: Aortic smooth muscle cell proliferation and endothelial nitric oxide synthase activity in fructose-fed rats. Am J Hypertens 2001; 14: 1135-1141.
40. Kamata K, Yamashita K: Insulin resistance and impaired endothelium-dependent renal vasodilation in fructose-fed hypertensive rats. Res Commun Mol Pathol Pharmacol 1999; 103: 195-210.
41. Nishimoto Y, Tomida T, Matsui H, Ito T, Okumura K: Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats. Hypertension 2002; 40: 190-194.
42. Majid DSA, Said KE, Omoro SA, Navar LG: Nitric oxide dependency of arterial pressure-induced change in renal interstitial hydrostatic pressure in dog. Circ Res 2001; 88: 347-351.
43. Ollerstam A, Pittner J, Persson A, Erik G, Thorup C: Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J Clin Invest 1997; 99: 2212-2218.
44. Yoshida H, Nakagawa M, Aoyama T, et al: Urinary kallikrein in Dahl-Iwai salt-sensitive and -resistant rats. Am J Hypertens 1997; 10: 73S-77S.